Latest Breaking News On - அனுபம் ராமா ஜுப்ம்ொர்கண் - Page 1 : vimarsana.com

Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript

Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United statesViatris theravance biopharmaRick winninghamDouglas tsaoAnupam rama jpmorganAnupam ramaAnna baranAndrew hindmanVikram purohitLiisa baykoMarc frahmRicharda grahamGail cohenErick grahamLiisa bayko evercoreRicke winningham

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Neurocrine Biosciences Inc (NASDAQ: NBIX) Popular Searches Operator Good day, everyone, and welcome to today s Neurocrine Biosciences Reports First Quarter Results. [Operator Instructions] It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Please go ahead.SPONSORED: 10 stocks we like better than Neurocrine Biosciences When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

United statesSan diegoTodd tushlaAnupam rama jpmorganJosh schimmer evercoreEiryw robertsPaul matteis stifelKyle ganoMyles minter william blairPhil nadeau cowenCarter gould barclaysJosh schimmerLaura chicoMatthewc abernethyPaul choiPhil nadeau

Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call Transcript

Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Theravance Biopharma Inc (NASDAQ: TBPH) Popular Searches Operator Ladies and gentlemen, good afternoon. I d like to welcome everyone to the Theravance Biopharma First Quarter 2021 Conference Call. [Operator Instructions] [Operator Instructions] And now, I would like to turn the call over to Gail Cohen, Vice President Corporate Communications. Please go ahead.SPONSORED: 10 stocks we like better than Theravance Biopharma When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

New yorkUnited statesRick winninghamViatris theravance biopharmaDouglas tsaoAnupam rama jpmorganAnupam ramaChin leeGenentech lillyMarc frahm cowenAndrew hindmanVikram purohitLiisa baykoRicharda grahamMarc frahmGail cohen

ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript

ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. ChemoCentryx Inc (NASDAQ: CCXI) Operator Good day and thank you for standing by. Welcome to the ChemoCentryx First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to Lee Roth of Burns McClellan. Please go ahead, sir.SPONSORED: 10 stocks we like better than ChemoCentryx

United statesVifor pharmaThomas schallAnupam rama jpmorganAnupam ramaRaymond jamesEdward tenthoff piper sandlerGlen massieMichelle gilsonTimur ivannikov raymond jamesHidradenitis suppurativaSteve seedhouseDburns mcclellanDavid jayneSusan kanayaYanan zhu

Constellation Pharmaceuticals (CNST) Q4 2020 Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by and welcome to the Constellation Pharmaceuticals Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference to your speaker today, Kia Khaleghpour, Vice President of Investor Relations and Communications. Please go ahead, ma am. Kia Khalaghpour Thank you, operator. Welcome to this conference call to discuss Constellation s fourth quarter 2020 financial results and operational performance. Please turn to slide 2. Before we begin, I want to point out that our presentation today will include forward-looking statements, which are subject to certain risks and uncertainties. Actual results may differ materially due to various important factors, including those described in the Risk Factors section as well as discussions of potential risk, uncertainty and other important factors in the Company s most recent filings with the Securities and Exchange Commission, including the C

United statesMarc frahmJeffrey humphreyPatrick trojerAnupam rama jpmorganAnupam ramaBrendan delaneyJigar raythathaGemma reeveMarc frahm cowenJeff humphreyKia khaleghpourExchange commissionConstellation pharmaceuticalsCompany analystConstellation pharmaceutical fourth quarter